In order to investigate, if CAIX is highly expressed in a relevant number of carcinoma patients and this expression is of consequence for the clinical outcome, we evaluated a TMA of esophageal carcinoma tissues by immunohistochemical staining (Figure 1(A), Table 2). The gene discussed is CA9; the disease is carcinoma.